Aldeyra Therapeutics (ALDX) - Management Comments

Aldeyra Therapeutics (ALDX) – Management Comments

Mar 28, 2024 07:03 AM Aldeyra Therapeutics (ALDX) Lays Out Clinical Development Plan for Resubmission of NDA for Reproxalap in Dry Eye Disease
Jan 4, 2024 07:05 AM Aldeyra Therapeutics (ALDX) Provides Clinical and Regulatory Update
Jan 7, 2021 07:23 AM
Dec 22, 2020 08:03 AM
Dec 17, 2020 08:11 AM
Dec 8, 2020 08:05 AM
Nov 5, 2020 09:13 AM
Sep 9, 2020 08:13 AM
Jul 7, 2020 08:07 AM
Jun 15, 2020 08:03 AM
Jun 4, 2020 08:01 AM
Apr 14, 2020 08:01 AM
Mar 12, 2020 07:00 AM
Jan 21, 2020 08:04 AM
Jan 14, 2020 08:05 AM
Dec 19, 2019 08:09 AM
Dec 3, 2019 07:01 AM
Nov 7, 2019 07:46 AM
Oct 31, 2019 07:14 AM
Sep 24, 2019 08:07 AM
Jun 24, 2019 08:07 AM
Apr 30, 2019 08:13 AM
Mar 26, 2019 07:04 AM
Feb 28, 2019 07:23 AM
Jan 29, 2019 08:05 AM
Dec 20, 2018 08:13 AM
Nov 14, 2018 07:02 AM
Sep 26, 2018 07:01 AM
Aug 9, 2018 07:34 AM
Jul 31, 2018 08:14 AM
Jul 24, 2018 08:05 AM
Jul 12, 2018 08:04 AM
May 15, 2018 07:32 AM
May 1, 2018 07:19 AM
Nov 29, 2017 08:17 AM
Oct 25, 2017 08:15 AM
Oct 24, 2017 08:10 AM
Oct 5, 2017 08:08 AM
Sep 12, 2017 07:07 AM
Jun 19, 2017 08:13 AM
Jun 14, 2017 06:52 AM
Apr 18, 2017 08:09 AM
Feb 7, 2017 08:10 AM
Sep 26, 2016 08:33 AM
Aug 9, 2016 07:04 AM
May 9, 2016 07:42 AM
Feb 29, 2016 07:04 AM
Dec 16, 2015 08:38 AM
Sep 29, 2015 08:33 AM
Apr 23, 2015 08:33 AM